Disclosures for "Phase 1/2 Trial Evaluating AOC 1044 in Healthy Volunteers and Participants with DMD Mutations Amenable to Exon 44 Skipping (DMD44): EXPLORE44 Trial Design"
-
Dr. Stahl has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Stahl has stock in Avidity Biosciences.
-
Dr. Ackermann has received personal compensation for serving as an employee of Avidity Biosciences.
-
Dr. Zhu has received personal compensation for serving as an employee of Avidity Biosciences. Dr. Zhu has stock in Avidity Biosciences.
-
Ms. Tami has stock in Ionis Pharmaceuticals. Ms. Tami has stock in Avidity Biosciences.
-
Steven G. Hughes has received personal compensation for serving as an employee of Avidity Biosciences. Steven G. Hughes has received personal compensation for serving as an employee of Arcturus Therapeutics. Steven G. Hughes has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Ionis Pharmaceuticals. Steven G. Hughes has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Arcturus Therapeutics. Steven G. Hughes has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Avidity Biosciences. Steven G. Hughes has stock in Arcturus Therapeutics. Steven G. Hughes has stock in Avidity Biosciences.
-
Dr. Konersman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Konersman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Konersman has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avidity . Dr. Konersman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Konersman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genentech/Roche. The institution of Dr. Konersman has received research support from Sarepta. The institution of Dr. Konersman has received research support from Novartis Gene Therapies. The institution of Dr. Konersman has received research support from Italfarmaco. The institution of Dr. Konersman has received research support from Fibrogen.
-
Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astellas. Dr. McDonald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Capricor Therapeutics. Dr. McDonald has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Catabasis. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Epirium Bio. Dr. McDonald has received personal compensation in the range of $0-$499 for serving as a Consultant for Italfarmaco. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Santhera Pharmaceuticals. Dr. McDonald has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC Therapeutics. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Capricor. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catabasis Pharmaceuticals. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Santhera Pharmaceuticals. The institution of Dr. McDonald has received research support from Sarepta Therapeutics. The institution of Dr. McDonald has received research support from PTC Therapeutics. The institution of Dr. McDonald has received research support from Santhera Pharmaceuticals. The institution of Dr. McDonald has received research support from Astellas. The institution of Dr. McDonald has received research support from Capricor Therapeutics. The institution of Dr. McDonald has received research support from Catabasis. The institution of Dr. McDonald has received research support from Epirium Bio. The institution of Dr. McDonald has received research support from Italfarmaco. Dr. McDonald has received research support from NS Pharma. The institution of Dr. McDonald has received research support from Pfizer. The institution of Dr. McDonald has received research support from NIH (NINDS). The institution of Dr. McDonald has received research support from NIDILRR. The institution of Dr. McDonald has received research support from Department of Defense. The institution of Dr. McDonald has received research support from Parent Project Muscular Dystrophy. The institution of Dr. McDonald has received research support from Muscular Dystrophy Association. Dr. McDonald has received personal compensation in the range of $500-$4,999 for serving as a Member National Advisory Board for Medical Rehabilitation Research with NIH.